Developing Enobosarm Using A SARM-Based Strategy for Muscle Preservation & Improved Body Composition

Time: 12:00 pm
day: Day One

Details:

• Enobosarm’s SARM-based action has been shown to prevent the loss of lean muscle mass during caloric restriction, which results in a more favorable body composition and sustained metabolic health
• This targeted strategy demonstrates the unique result of preferential fat loss over muscle loss, which provides a higher quality of weight reduction compared to other obesity treatments
• The development of enobosarm successfully addresses the clinical challenge of muscle wasting, leading to the outcome of improved physical function and a reduction in sarcopenic obesity

Speakers:

Mitchell Steiner Mitchell S. Steiner, M.D., F.A.C.S. has served as President and Chief Executive Officer of the Company and as a director of the Company since October Read more